FKBP5 and depressive symptom measurement: Post hoc analysis revealed that this was driven by + 39.8% higher FKBP5 gex in subjects with schizophrenia (t = 3.226, P = 0.001403, FDR = 0.004209) and depression (+ 23.86%; t = 2.478, P = 0.01377, FDR = 0.020655) (Fig. 1a).